BAJAJ BROKING

Notification close image
No new Notification messages
card image
🚨 TRADING HOLIDAY 🚨
The NSE and BSE will remain closed for trading and settlement on Wednesday, August 27, 2025, on account of Ganesh Chaturthi.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

524604

ADLINE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Adline Chemab Share Price Update

As of the latest trading session, Adline Chemab share price is currently at ₹ 17.95, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 17.90 and ₹ 17.95. Over the past year, Adline Chemab has achieved a return of 0.78 %. In the last month alone, the return has been 14.69 %. Read More...

Investment Returns

Over 1 Month 14.69% Over 3 Months 24.56% Over 6 Months 16.25% Over 1 Year 0.78%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Adline Chemab fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    10.50

  • P/E Ratio (TTM)

    -179.50

  • Beta

    1.00

  • Book Value / share

    -2.55

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -0.05

info icon alternate text

Adline Chemab Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit -0.05
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.03
Effective Tax Rate (%) 16.66
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.09
Net Profit 0.21
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.04
EBITDA 0.19
Effective Tax Rate (%) -31.25
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.13
Net Profit -0.12
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.10
Effective Tax Rate (%) 7.69
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.10
Net Profit -0.09
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.07
Effective Tax Rate (%) 10.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.13
Net Profit -0.13
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.10
Effective Tax Rate (%) 7.69
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.45
Net Profit -0.13
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.22
EBITDA -0.07
Effective Tax Rate (%) 33.33
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.30
Net Profit -0.27
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.05
EBITDA -0.18
Effective Tax Rate (%) 10.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.88
Net Profit -4.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -7.24
EBITDA -4.14
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.74
Operating Expense 1.39
Net Profit 0.72
Net Profit Margin (%) 97.29
Earnings Per Share (EPS) 1.23
EBITDA 1.08
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 6.33
Operating Expense 7.61
Net Profit -1.28
Net Profit Margin (%) -20.22
Earnings Per Share (EPS) -2.19
EBITDA -0.22
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share -2.55
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share -2.35
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -2.68
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.45
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.53
ROE % -10.55
ROCE % -7.40
Total Debt to Total Equity 0.83
EBITDA Margin -14.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.30
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.04
EBITDA Margin -3.63
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 0.07
Total Liabilities 0.07
Total Equity -1.49
Share Outstanding 5850000
Price to Book Ratio -5.20
Return on Assets (%) -175.09
Return on Capital (%) 2360.71
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 0.04
Total Liabilities 0.04
Total Equity -1.37
Share Outstanding 5850000
Price to Book Ratio 0.00
Return on Assets (%) -644.07
Return on Capital (%) 1998.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 0.06
Total Liabilities 0.06
Total Equity -1.56
Share Outstanding 5850000
Price to Book Ratio -2.01
Return on Assets (%) -6858.26
Return on Capital (%) 1806.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 4.87
Total Liabilities 4.87
Total Equity 2.64
Share Outstanding 5850000
Price to Book Ratio 1.45
Return on Assets (%) 14.72
Return on Capital (%) 18.1
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments -0.15
Total Assets 5.63
Total Liabilities 5.63
Total Equity 1.93
Share Outstanding 5850000
Price to Book Ratio 1.55
Return on Assets (%) -22.77
Return on Capital (%) -28.96
Particulars MAR 2025 (Values in Cr)
Net Income -0.20
Cash from Operations -0.32
Cash from Investing 0.00
Cash from Financing 0.24
Net change in Cash 0.02
Free Cash Flow -0.32
Particulars MAR 2024 (Values in Cr)
Net Income -0.30
Cash from Operations -0.16
Cash from Investing 0.00
Cash from Financing 0.14
Net change in Cash -0.01
Free Cash Flow -0.16
Particulars MAR 2023 (Values in Cr)
Net Income -4.23
Cash from Operations 0.01
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.01
Free Cash Flow 0.01
Particulars MAR 2022 (Values in Cr)
Net Income 0.71
Cash from Operations 0.21
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow 0.21
Particulars MAR 2021 (Values in Cr)
Net Income -1.28
Cash from Operations -0.29
Cash from Investing 0.11
Cash from Financing -0.03
Net change in Cash -0.20
Free Cash Flow -0.28
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 33.30 13.59 1.82 255.19 30.00 / 69.75
BLISS GVS PHARMA LTD 159.00 15.73 1.59 1677.41 105.05 / 190.65
CIPLA LTD 1601.10 23.98 4.14 129329.50 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 323.75 9.12 2.62 952.83 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2799.20 50.08 24.30 47420.14 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 33.30 18.10 5.26 255.19 30.00 / 69.75
AMRUTAJAN HEALTH LTD 708.10 37.55 6.26 2047.16 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8297.10 98.09 26.92 20742.75 6222.35 / 10653.05
BLISS GVS PHARMA LTD 159.00 23.77 1.58 1677.41 105.05 / 190.65

Adline Chemab Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
17.95 4.97 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 16.80
  • 26 Days 16.40
  • 10 Days 16.50
  • 50 Days 16.30
  • 12 Days 16.50
  • 100 Days 16.50
  • 20 Days 16.40
  • 200 Days 16.30
17.93 PIVOT

First Support

17.92

First Resistance

17.97

Second Support

17.88

Second Resistance

17.98

Third Support

17.87

Third Resistance

18.02

RSI

59.18

ADX

24.17

MACD

0.02

Williams % R

-3.90

Commodity Channel Index (CCI)

151.11

Date

2025-08-21

Week

740.00

Same Day

300.00

Month

400.00

1 Year

1.01

3 Year

0.51

Over 1 Month

14.69%

down

Over 1 Year

0.78%

down

Over 3 Months

24.56%

down

Over 3 Years

25.04%

down

Over 6 Months

16.25%

down

Over 5 Years

29.12%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

Adline Chemab shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

Adline Chemab corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Adline Chemab Share Price

Adline Chem Lab Limited (Formerly known as Kamron Laboratories Limited) was incorporated in 1988 by its Promoter, Mr Kamlesh J Laskari. The Company name was changed from Kamron Laboratories Limited' to Adline Chem Lab Limited effective on October 13, 2021. Adline is a dynamic and innovative multinational company specializing in providing integrated solutions and services across diverse industries. It is engaged in manufacturing of pharmaceutical chemicals, fine chemicals, agrochemical products. ADLINE's mission is to revolutionize the industries it serves by providing unparalleled excellence in chemicals, laboratory and lab products establishment, active pharmaceutical ingredients (API), pharmaceuticals, agro/agro trade, biotech, and fertilizers.

In May 1990, the Company started production at its site in Rakanpur, Gujarat. Initially, the Company was manufacturing tablets, capsules and liquid orals. In 1993, it started manufacture of injections.

At present, the company is marketing its products in many states of India and also exporting to a few countries. But over the period of last three decades, there were major changes in the manufacturing technology and building layout due to which the company's plant became obsolete. After taking shareholders approval, the company had discontinued the production in 2019 and sold its land and building in December 2019.

Currently the company is continuing the marketing activities and getting its products manufactured from various manufacturers.

Mr. Hemant A. Parikh acquired the shares of the Company via Open Offer process in October, 2023 and has become the Promoter of the Company in 2024.

Parent organization Indian Private
NSE symbol [-]
Founded 1988
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Adline Chem Lab Ltd?

Answer Field

Adline Chem Lab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 17.95 as on Aug 21 2025 12:00 AM.

What is the Market Cap of Adline Chem Lab Ltd Share?

Answer Field

The market cap of Adline Chem Lab Ltd for NSE ₹ 0.00 & for BSE ₹ 10.50 as on Aug 21 2025 12:00 AM.

What is the 52 Week High and Low of Adline Chem Lab Ltd?

Answer Field

The 52 Week High and Low of Adline Chem Lab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 26.01 and ₹ 9.40.

What is 1 year return for Adline Chem Lab Ltd?

Answer Field

The 1 year returns on the stock has been 0.78%.

What is the P/E Ratio of Adline Chem Lab Ltd Share?

Answer Field

As on Aug 21 2025 12:00 AM the price-to-earnings (PE) ratio for Adline Chem Lab Ltd share is -179.50.

What is the PB ratio of Adline Chem Lab Ltd Share?

Answer Field

As on Aug 21 2025 12:00 AM, the price-to-book (PB) ratio for Adline Chem Lab Ltd share is -2.55.

How to Buy Adline Chem Lab Ltd Share?

Answer Field

You can trade in Adline Chem Lab Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Adline Chem Lab Ltd Share on Bajaj Broking App?

Answer Field

To buy Adline Chem Lab Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Adline Chem Lab Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91